Weekly Digest – September 2026 Weekly Digest – September 2026 23 September 2026: SOTIO advances SOT106 with dual FDA designations for Sarcoma SOTIO announced that SOT106 received two additional FDA designations: Orphan Drug Designation for soft tissue sarcoma and Fast […]